期刊文献+

miR-204通过下调Bcl-2和Sirt1表达抑制肝癌细胞生长 被引量:16

Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression
下载PDF
导出
摘要 目的探讨微小RNA 204(miR-204)在肝细胞癌中的表达、临床意义及可能分子机制。方法收集手术切除的60例肝细胞癌及对应癌旁肝组织,实时定量PCR(qRT-PCR)检测miR-204在肝癌及癌旁组织中的表达,免疫组织化学染色检测miR-204下游潜在靶点Bcl-2与组蛋白脱乙酰酶1(Sirt1)的表达;用人工合成的miR-204模拟物转染人SMMC-7721肝癌细胞,MTT法及流式细胞术检测SMMC-7721细胞的增殖、凋亡的情况,qRT-PCR、Western blot法分别检测Bcl-2与Sirt1的mRNA和蛋白表达。结果 miR-204在肝癌组织中表达水平显著低于对应癌旁组织;肝癌组织中miR-204低表达与肿瘤大小、肿瘤个数、肿瘤TNM分期显著相关;miR-204低表达组Bcl-2与Sirt1蛋白表达显著高于miR-204高表达组,相关性分析结果显示肝癌组织中miR-204与Bcl-2、Sirt1蛋白表达呈显著负相关;miR-204可显著抑制SMMC-7721细胞的增殖并促进其凋亡,并下调Bcl-2与Sirt1的mRNA与蛋白表达水平。结论 miR-204在肝癌组织中表达下调并与肝癌恶性临床病理特征有关,miR-204抑制肝癌细胞增殖、促进其凋亡的作用可能与下调Bcl-2和Sirt1表达有关。 Objective To investigate the level of microRNA-204 (miR-204) in human hepatocellular carcinoma (HCC) and its effect on the potential mechanism of tumorgenesis. Methods Real-time quantitative PCR (qRT-PCR) was applied to detect the expression of miR-204 in HCC (n = 60) and the corresponding tumor-adjacent normal tissues. The expressions of Bcl-2 and Sirtl were measured by immunohistochemistry (IHC). The artificial miR-204 was transiently transfected into human SMMC-7721 cells in vitro. The proliferation and apoptosis of the cells were detected by MTF assay and flow cytometry, respectively. The expression levels of Bcl-2 and Sirt1 mRNA and protein were determined by qRT-PCR and Western blotting, respectively. Results The expression level of miR-204 in HCC tissues was significantly lower than that in the adjacent normal tissues, and it was associated with tumor size, number of tumors and advanced TNM stage. The expressions of Bcl-2 and Sirtl in the lower miR-204 level group were both higher than those in the higher miR-204 level group. Correlation analysis showed that miR-204 expression was negatively correlated with Bcl-2 and Sirt1 protein expression levels. Over-expressed miR-204 in SMMC-7721 cells suppressed cell proliferation and promoted cell apoptosis, and down-regulated mRNA and protein expressions of both Bcl-2 and Sirt1. Conclusion The expression of miR-204 in HCC tissues was significantly lower than that in tumor-adjacent normal tissues, miR-204 could inhibit HCC cell proliferation and induce apoptosis by down-regulating the expressions of Bcl-2 and Sirt1.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2015年第2期168-172,共5页 Chinese Journal of Cellular and Molecular Immunology
关键词 miR-204 肝细胞癌 凋亡增殖 BCL-2 SIRT1 miR-204 hepatocellular carcinoma proliferation apoptosis Bcl-2 Sirt1
  • 相关文献

参考文献20

  • 1周振宇,涂康生,张竞,郑鑫,高洁,姚英民,刘青光.Fbxw7在肝癌中的表达及与肝癌细胞增殖相关性研究[J].细胞与分子免疫学杂志,2012,28(12):1303-1306. 被引量:26
  • 2李超,涂康生,郑鑫,张竞,拓航,高洁,姚英民,刘青光.MicroRNA-218在肝细胞癌中的表达及功能[J].南方医科大学学报,2013,33(8):1127-1131. 被引量:22
  • 3Yang X, Zhang XF, Lu X, et al. microRNA26a suppresses angiogenesis in hunmn hepatocellar carcinoma by targeting HGF-cMet pathway [ J ]. Hepatology, 2014, 59(5) : 1874 - 1885.
  • 4Duan X, Hu J, Wang Y, et al. microRNA-145 : a promising biomaer for hepatocellular carcinoma ( HCC ) [ J 1. Gene, 2014, 541 ( 1 ) : 67 - 68.
  • 5Zhou J, Lu S, Yang S, et al. microRNA-127 post-transcriptionally downregulates Sept7 and suppresses cell growth in hepatocelluar carcinoma cells [ J ]. Cell Physiol Biochem, 2014, 33 ( 5 ) : 1537 - 1537.
  • 6张一琳,汤建中,刘宏鹏,张兆波,徐文锦,魏军,徐广贤.抑制miR-21表达的腺病毒载体构建、病毒包装及其对HepG2细胞的作用[J].细胞与分子免疫学杂志,2012,28(12):1265-1268. 被引量:1
  • 7Ma L, Deng X, Wu M, et al. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-asscciated nasopharyngeal carcinoma cells [ J ]. FEBS lett, 2014, 588 ( 9 ) : 1562 - 1570.
  • 8Vimalraj S, Miranda PJ, Ramyakrishna B, et al. Regulation of breast cancer and bone metastasis by microRNAs [ J ]. Dis Markers, 2013, 35(5) : 369 -387.
  • 9Ryan J, Tivnan A, Fay J, et al. microRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome[J]. Br J Cancer, 2012, 107(6) : 967 -976.
  • 10Zeng L, Yu J, Huang T, et al. Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma[ J/OL]. BMC gennmics, 2012, 13 ( Suppl 8) : $14.

二级参考文献63

共引文献84

同被引文献149

  • 1惠晓丽,王惠芳,姚孝礼.β细胞凋亡与2型糖尿病[J].国外医学(内分泌学分册),2005,25(1):22-25. 被引量:8
  • 2周红林,刘建新,周俐,周青,连其深.臭牡丹提取物抗炎镇痛抗过敏作用的实验研究[J].中国新药杂志,2006,15(23):2027-2029. 被引量:17
  • 3王卫东,陈正堂.Bcl-2/Bax比率与细胞“命运”[J].中国肿瘤生物治疗杂志,2007,14(4):393-396. 被引量:161
  • 4杨振丽,刘玉琴.癌症相关代谢紊乱综合征[J].中国肿瘤临床,2007,34(24):1428-1432. 被引量:11
  • 5Jemal A, Bray F, Center MM ,et al. Global cancer statistics[ J]. CA Cancer J Clin ,2011,61:69 - 90.
  • 6Schefler AC, Cicciarelli N,Feuer W,el al. Macular retinoblastoma, evaluation of tumor control, local complications, and visual out-comes for eyes trealed with chemotherapy and repetitive foveall as- erlation [ J]. Ophthalmology,2007 114( 1 ) : 162 - 169.
  • 7Gould J. Gene therapy : Genie in a vector [ J ]. Nature, 2014,515 (7528) :SI60 - 161.
  • 8Lujambio A, Lowe SW. The microcosmos of cancer [ J ]. Nature, 2012,482 (7385) :347 - 355.
  • 9Ma L, Deng X, Wu M, et al. Down - regulation of miRNA - 204 by LMP - 1 enhances CDC42 activity and facilitates invasion of EBV - associated nasopharyngea| carcinoma cells [ J ]. FEBS Let,2014, 588(9) : 1562 - 1570.
  • 10Ryan J,Tivnan A, Fay J, et al. microRNA - 204 increases sensitivi- ty of neuroblastoma cells to cisp|atin and is associated with a fa- vourable clinical outcome [ J ]. Br J Cancer, 2012,107 (6) :967 - 976.

引证文献16

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部